NEW YORK and DELTA, British Columbia, Oct. 17, 2018 — Investorideas.com, a leading investor news resource covering security and cannabis stocks releases a sector snapshot as the industry realizes a significant milestone with the official legalization in Canada today on a federal level. Experts and thought leaders weigh in on this historic event giving insight as to what this means to the U.S. and global markets and their companies.
“Canadians are expected to spend as much as $7.17 billion on cannabis products in 2019 and increase their overall consumption by up to 35 per cent once recreational cannabis is legalized,” according to a report by Deloitte. “Legal recreational cannabis sales could generate up to $4.34 billion in sales, accounting for more than half of total cannabis sales but the illegal market could still be worth more than $1 billion a year.”
From Deloitte’s news, “Canada is in a unique position as the first G7 country on the cusp of legalizing recreational cannabis,” said Mark Whitmore, Vice Chair and Global Leader, Deloitte Private. “The move to legalize recreational cannabis has sparked a wave of innovation and entrepreneurship, similar to Canada’s technology sector which will create jobs for Canadians, new opportunities for businesses and revenues for governments.”
Seeing new opportunities, Roger Ralston, CEO and Chairman of DirectView Holdings, Inc. (OTC: DIRV), a video surveillance solutions technology company that recently announced its expansion in the cannabis sector said, “The legalization of cannabis in Canada this week is a huge step for the country and the sector. The decision comes with a lot of responsibility for all involved.”
He went on to say, “For businesses dealing in cannabis/CBD, safety and security is of the upmost importance and a legal requirement. This also has the potential to accelerate legalization here in the United States. We anticipate the legalization will spark the security and surveillance industry and DirectView stands ready to meet the needs in security and surveillance requirements of all industries, including the cannabis industry. We further see other security related needs such as guard services, armored vehicles for movements of cash and products increasing greatly.”
Altitude Investment Management in a released statement noted, “Canada is the second country in the world, after Uruguay, to legalize cannabis for both medical purposes and adult use and it is the first country in North America to do so,” observed Jon Trauben, partner at Altitude.
He added, “We believe that the legalization in Canada offers a roadmap to invest in the companies that will form the basis of the legal cannabis industry in the coming years. Altitude Investment Management’s portfolio strategy rests on this premise, and we are confident that the growth of the legalized industry will continue to provide compelling investment opportunities globally.”
HEMP Magazine publisher, Eugenio Garcia shared his thoughts with Investor Ideas on Canada’s legalization saying, “Legalization in Canada will now allow all of its people access to the CBD products they are looking for without needing to have a doctor’s recommendation. This will be especially helpful in regard to products that use the “entourage” effect and blend both high CBD levels with THC percentages.”
When asked how public companies like Tilray Inc., Canopy Growth, Aurora Cannabis Inc. and Cronos Group are influencing the stock market and the economy as well as the future of the cannabis industry, he said, “These companies and the activity of investment around them have sent the valuations of these companies and others in the space into way above realistic levels. That being equal the exposer in the mainstream media of such large amounts of real money being put into the cannabis space is having a positive effect on the “normalization” of the industry from a main stream perception aspect.“
Tilray was one of the first companies to be licensed to produce medical cannabis in Canada and was the first licensed producer of medical cannabis in the world to have its facility Good Manufacturing Practices (GMP) certified in accordance with European Medicine Agency (EMA) standards. The company currently serves thousands of patients, physicians, pharmacies, governments, hospitals and researchers in eight countries, spanning four continents, through its affiliated entities in Australia and New Zealand (Tilray Australia New Zealand Pty Ltd), Canada (Tilray Canada Ltd), Germany (Tilray Deutschland GmbH) and Portugal (Tilray Portugal Unipessoal Lda).
As legalization expands globally, one of Canada’s noted leaders also has its footprint beyond the Canadian borders. Aphria Inc., announced yesterday, “It commends the Government of the United Kingdom for its decision last week to legalize medical cannabis. The Company is pleased to also announce that is has formed an alliance with noted UK-based neurologist and rehabilitation physician Professor Michael Barnes, MD, FRCP, a leading voice on medical cannabis policy in Europe.”
From the news, “I applaud the UK government for taking this step to legalize medical cannabis,” said Vic Neufeld, Chief Executive Officer of Aphria. “It’s great news for patients in need across the UK and represents another major milestone in the advancement of medical cannabis around the world.”
Bottom line: today’s Canadian legalization is historic but the global shift to legalization is the biggest story for investors.
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com – News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts, articles, podcasts and videos talking about cannabis, crypto, technology including AI and Iota, mining, sports biotech, water, renewable energy and more. Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column and the Cleantech and Climate Change Podcast.
This news is published on the Investorideas.com Newswire – News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring DIRV is a paid for news release on the Investorideas.com newswire. Learn more about costs and our newswire service https://www.investorideas.com/News-Upload/
Contact Investorideas.com 800-665-0411